Canndoc has been pioneering Pharma-Grade cannabis for more than 12 years. Over the years, Canndoc provided more than 750,000 doses to 20,000 patients, establishing its position as a venerable player in this global industry, demonstrating significant expertise across the entire value chain from research, cultivation, and processing, to product development and advanced GMP clinical trials pipeline initiation.
Driven by the mission of meeting patients’ needs and improving their quality of life, Canndoc holds product efficacy to be of paramount importance, delivering Good Manufacturing Practice (GMP) pharma-grade cannabis solutions to achieve better patient health and treatment outcomes.
CB2 Insights is a healthcare services and technology company, working to positively impact patient health outcomes. Our mission to improve the lives of patients through the prevention and treatment of health conditions and using proprietary technology to monitor, assess, and generate insights to help improve patient outcomes. Improving Patient Health Outcomes through Real World Evidence.
Seach Medical Group, pioneering the field of medical cannabis in Israel and worldwide since 2008. Founded by the Sarid family, 3rd generation of farming experts, who were exposed to the great medical potential of cannabis during their father’s unfortunate sickness. With the growing awareness about cannabis and its medicinal benefits, the Sarid family has spent many years researching and developing medical cannabis products of uncompromising quality with the goal of improving the lives of thousands of patients. The vast knowledge and experience gained over the last decade has allowed the company to continuously improve the quality of its products, while advancing the company’s technological capabilities. Seach’s wide variety of exclusive strains, global network of strategic partnerships, groundbreaking clinical trials, and development of novel cannabis technology, gives Seach a leading presence in the global cannabis industry.
Founded in Toronto Canada in 2016, Strainprint Technologies is the leader in demand-side cannabis data and analytics. Strainprint was created by patients for patients with a mission to advance the scientific understanding of cannabis and its legitimization as a mainstream therapy. We support cannabis patients, practitioners, industry and government with the most sophisticated and easy to use digital technologies for responsible cannabis use and global research. Strainprint is privacy compliant, military-grade encrypted and all patient data is completely anonymized and at rest in Canada.